Onconova Therapeutics (ONTX) Announces Encouraging Clinical Data Supporting the Anti-Cancer Activity of Rigosertib-Nivolumab Combination in Advanced KRAS+ Non-Small Cell Lung Cancer
Go back to Onconova Therapeutics (ONTX) Announces Encouraging Clinical Data Supporting the Anti-Cancer Activity of Rigosertib-Nivolumab Combination in Advanced KRAS+ Non-Small Cell Lung Cancer| ONCONOVA THERAPTCS (NASDAQ: ONTX) | Delayed: 1.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $6.71 | |||
| Open | $22.37 | 52 Week Low | $0.32 | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $-2.36 | |||
| Volume | 3,728 | |||||
